| Literature DB >> 34267604 |
Peter Soldos1, Zsuzsanna Besenyi2, Katalin Hideghéty3, László Pávics2, Ádám Hegedűs1, Levente Rácz1, Bence Kopper1.
Abstract
Skeletal muscle status and its dynamic follow up are of particular importance in the management of several diseases where weight and muscle mass loss and, consequently, immobilization occurs, as in cancer and its treatment, as well as in neurodegenerative disorders. But immobilization is not the direct result of body and muscle mass loss, but rather the loss of the maximal tension capabilities of the skeletal muscle. Therefore, the development of a non-invasive and real-time method which can measure muscle tension capabilities in immobile patients is highly anticipated. Our aim was to introduce and evaluate a special ultrasound measurement technique to estimate a maximal muscle tension characteristic which can be used in medicine and also in sports diagnostics. Therefore, we determined the relationship between the results of shear wave elastography measurements and the dynamometric data of individuals. The measurements were concluded on the m. vastus lateralis. Twelve healthy elite athletes took part in our preliminary proof of principle study-five endurance (S) and seven strength (F) athletes showing unambiguously different muscle composition features, nine healthy subjects (H) without prior sports background, and four cancer patients in treatment for a stage 3 brain tumor (T). Results showed a high correlation between the maximal dynamometric isometric torque (Mmax) and mean elasticity value (E) for the non-athletes [(H + T), (r = 0.795)] and for the athletes [(S + F), (r = 0.79)]. For the athletes (S + F), the rate of tension development at contraction (RTDk) and E correlation was also determined (r = 0.84, p < 0.05). Our measurements showed significantly greater E values for the strength athletes with fast muscle fiber dominance than endurance athletes with slow muscle fiber dominance (p < 0.05). Our findings suggest that shear wave ultrasound elastography is a promising method for estimating maximal muscle tension and, also, the human skeletal muscle fiber ratio. These results warrant further investigations with a larger number of individuals, both in medicine and in sports science.Entities:
Keywords: dynamometry; muscle stiffness; muscle thickness; shear wave elastography; strength parameters
Mesh:
Year: 2021 PMID: 34267604 PMCID: PMC8275576 DOI: 10.3389/pore.2021.1609798
Source DB: PubMed Journal: Pathol Oncol Res ISSN: 1219-4956 Impact factor: 3.201
FIGURE 1Flow diagram of research.
FIGURE 2Ultrasonography measurement on vastus lateralis and the points of measurements on the skin (A,B). Sagittal plane panoramic ultrasound image of right leg’s m. quadriceps femoris—vastus lateralis of same individual; the red stars sign the measurement points (C).
Body composition data (mean ± SD) for the samples.
| Sample | BH (cm)* | BW (kg)* | BF (%) | VF (%) | BM % | BMI* |
| F | 188.7 ± 6.2 | 90.3 ± 16.4 | 17.6 ± 6.8 | 6.5 ± 3.7 | 40.4 ± 4.2 | 25.3 ± 4.1 |
| S | 166.2 ± 6.9 | 54.6 ± 12 | 19.1 ± 5.2 | 4 ± 2.8 | 36.1 ± 4.5 | 19.7 ± 2.5 |
| H | 174.5 ± 11.6 | 70 ± 15,9 | 25.3 ± 5.5 | 5.4 ± 2.6 | 33.7 ± 4.9 | 22.7 ± 2.5 |
| T | 173.5 ± 10.8 | 69.0 ± 18.9 | 27.6 ± 5.0 | 5.3 ± 2.6 | 30.9 ± 3.9 | 22.5 ± 3.2 |
*Indicates significant difference between F and S sample; + indicates significant difference between athlete (F + S) and non-athlete (H + T), p < 0.05.
F, fast muscle fiber dominance athlete group; S, slow muscle fiber dominance athlete group; H, healthy non-athlete group; T, group of cancer patients.
H, body height; BW, body weight; BF, body fat percentage; VF, visceral fat percentage; BM, body muscle percentage; BMI, body mass index.
Ultrasound data in isometric max contraction of the muscle for the samples.
| Subjects | E (kPa)* | dA (mm) I. | dF (mm) I. | dA (mm) II. | dF (mm) II. | dA (mm) III. | dF (mm) III. |
| F | 44.4 ± 6.2 | 27.2 ± 0.7 | 29.7 ± 4.0 | 27.3 ± 0.8 | 29.3 ± 0.8 | 19.5 ± 0.6 | 20.5 ± 0.7 |
| S | 28.2 ± 3.5 | 17.0 ± 0.7 | 18.3 ± 4.4 | 18.9+0.4 | 21.2 ± 0.4 | 18.3 ± 0.2 | 21.9 ± 0.4 |
| H | 28.6 ± 25.8 | 16 ± 15.7 | 18.8 ± 2.3 | 21.3 ± 4.2 | 14.9 ± 1.9 | 19.4 ± 3.0 | 19.4 ± 3.0 |
| T | 20.7 ± 24.6 | 15.3 ± 15.7 | 18.1 ± 18.5 | 18.6 ± 19.5 | 14.9 ± 15 | 20.0 ± 19.2 | 20.0 ± 19.2 |
*Indicates significant difference between F and S sample; + indicates significant difference between athlete (F + S) and non-athlete (H + T), p < 0.05.
F, fast muscle fiber dominance athlete group; S, slow muscle fiber dominance athlete group; H, healthy non-athlete group; T, group of cancer patients.
E, mean elasticity values; dA, anatomical cross–sectional diameter; dF, physiological cross-sectional diameter.
Ultrasound data during resting phase of the muscle for the samples.
| Subjects | E (kPa) I. | dA (mm) I. | dF (mm) I. | dA (mm) II. | dF (mm) II. | dA (mm) III. | dF (mm) III. |
| F | 21.3 ± 3.5 | 25.6 ± 0.7 | 27.1 ± 4.1 | 26.7 ± 0.6 | 28.6 ± 0.7 | 19.6 ± 0.7 | 20.5 ± 0.7 |
| S | 17.8 ± 1.8 | 20.2 ± 0.5 | 22 ± 0.5 | 20.2 ± 0.3 | 21.7 ± 0.3 | 19.0 ± 0.3 | 20.7 ± 0.3 |
| H | 17.3 ± 4.6 | 19.8 ± 4.3 | 21.4 ± 4.5 | 20.3 ± 4.4 | 23 ± 4.3 | 16.6 ± 3.2 | 18.8 ± 3.8 |
| T | 17.3 ± 1.9 | 18.7 ± 5.7 | 20 ± 5.6 | 17.4 ± 1.9 | 20.0 ± 3.3 | 16 ± 2.8 | 17.5 ± 3.1 |
*Indicates significant difference between F and S sample; + indicates significant difference between athlete (F + S) and non-athlete (H + T), p < 0.05.
F, fast muscle fiber dominance athlete group; S, slow muscle fiber dominance athlete group; H, healthy non-athlete group; T, group of cancer patients.
E, mean elasticity values; dA, anatomical cross–sectional diameter; dF, physiological cross-sectional diameter.
Dynamometric data (mean ± SD) for the F and S athletes’ samples.
| Sample | Mmax (Nm)* | RTDk (Nm/s)* | RTDr (Nm/s) |
| F | 325.8 ± 37.5 | 8.2 ± 1.3 | 1.6 ± 0.5 |
| S | 190.1 ± 28.8 | 5.9 ± 0.2 | 1.16 ± 0.1 |
*Significant difference between F and S sample (p<0.05).
F, fast muscle fiber dominance athlete group; S, slow muscle fiber dominance athlete group.
Mmax, maximal isometric torque; RTDk, rate of tension development at contraction; RTDr, rate of tension development at release.
FIGURE 3BH-E (kPa) graph indicating a correlation between variables for the athlete (F + S) sample (r = 0.76, p < 0.05) (A) and for the non-athlete (H + T) sample (r = 0.58, p < 0.05) (B).
FIGURE 4BW-E (kPa) graph indicating a correlation between variables for the athlete (F + S) sample (r = 0.76, p < 0.05) (A) and for the non-athlete (H + T) sample (r = 0.55, p = 0.058) (B).
FIGURE 5Mmax-E (kPa) graph indicating a significant correlation between variables for the athlete (F + S) sample (r = 0.79; p < 0.05) (A); and for the non-athlete (H + T) sample (r = 0.816, p < 0.05) (B) measured in isometric max contraction.
FIGURE 6RTDk-E graph indicating a correlation between variables for the athlete (F + S) sample (r = 0.84) measured in isometric max contraction.
FIGURE 7Differences in mean elasticity values between relaxation (A) and contraction (B) phase in shear wave examination of right leg’s m. quadriceps femoris—vastus lateralis (E, mean elasticity value; d, depth).